Forte Biosciences, Inc. (FBRX)
Total Valuation
FBRX has a market cap or net worth of $26.35 million. The enterprise value is -$10.78 million.
Market Cap | 26.35M |
Enterprise Value | -10.78M |
Important Dates
The last earnings date was Monday, March 18, 2024, after market close.
Earnings Date | Mar 18, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
FBRX has 36.39 million shares outstanding. The number of shares has increased by 81.61% in one year.
Shares Outstanding | 36.39M |
Shares Change (YoY) | +81.61% |
Shares Change (QoQ) | -16.62% |
Owned by Insiders (%) | 10.83% |
Owned by Institutions (%) | 56.17% |
Float | 22.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.75 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.46, with zero debt.
Current Ratio | 10.46 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -94.30% and return on invested capital (ROIC) is -91.99%.
Return on Equity (ROE) | -94.30% |
Return on Assets (ROA) | -81.40% |
Return on Capital (ROIC) | -91.99% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.50M |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.81% in the last 52 weeks. The beta is 1.65, so FBRX's price volatility has been higher than the market average.
Beta (1Y) | 1.65 |
52-Week Price Change | -28.81% |
50-Day Moving Average | 0.68 |
200-Day Moving Average | 0.74 |
Relative Strength Index (RSI) | 51.29 |
Average Volume (30 Days) | 35,157 |
Short Selling Information
The latest short interest is 42,181, so 0.12% of the outstanding shares have been sold short.
Short Interest | 42,181 |
Short Previous Month | 66,590 |
Short % of Shares Out | 0.12% |
Short % of Float | 0.19% |
Short Ratio (days to cover) | 1.40 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -32.49M |
Pretax Income | -31.48M |
Net Income | -31.48M |
EBITDA | -31.47M |
EBIT | -31.48M |
Earnings Per Share (EPS) | -$1.00 |
Balance Sheet
The company has $37.13 million in cash and no debt, giving a net cash position of $37.13 million or $1.02 per share.
Cash & Cash Equivalents | 37.13M |
Total Debt | n/a |
Net Cash | 37.13M |
Net Cash Per Share | $1.02 |
Equity / Book Value | 35.31M |
Book Value Per Share | 0.97 |
Working Capital | 34.66M |
Cash Flow
In the last 12 months, operating cash flow was -$28.71 million and capital expenditures -$88,000, giving a free cash flow of -$28.79 million.
Operating Cash Flow | -28.71M |
Capital Expenditures | -88,000 |
Free Cash Flow | -28.79M |
FCF Per Share | -$0.91 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
FBRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -81.61% |
Shareholder Yield | -81.61% |
Earnings Yield | -119.47% |
FCF Yield | -109.29% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 16, 2020. It was a reverse split with a ratio of 1:15.
Last Split Date | Jun 16, 2020 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |